Foghorn Therapeutics Inc (FHTX)

Dec 20, 2024

FY2028 EPS Estimate for Foghorn Therapeutics Cut by Analyst - Defense World

Dec 20, 2024

Dec 20, 2024

HC Wainwright Has Positive Forecast for FHTX FY2024 Earnings - Defense World

Dec 20, 2024

Dec 19, 2024

Charles Schwab Investment Management Inc. Grows Position in Foghorn Therapeutics Inc. (NASDAQ:FHTX) - Defense World

Dec 19, 2024

Dec 19, 2024

Wedbush Reduces Earnings Estimates for Foghorn Therapeutics - MarketBeat

Dec 19, 2024

Dec 19, 2024

HC Wainwright Issues Optimistic Estimate for FHTX Earnings - MarketBeat

Dec 19, 2024

Dec 18, 2024

Foghorn Therapeutics price target lowered to $13 from $20 at H.C. Wainwright - Yahoo Finance

Dec 18, 2024

Dec 17, 2024

Short Interest in Foghorn Therapeutics Inc. (NASDAQ:FHTX) Decreases By 9.7% - MarketBeat

Dec 17, 2024

Dec 17, 2024

Foghorn Therapeutics shares target cut, buy rating on positive outlook By Investing.com - Investing.com Canada

Dec 17, 2024

Dec 17, 2024

Foghorn Therapeutics (NASDAQ:FHTX) Given New $14.00 Price Target at Jefferies Financial Group - Defense World

Dec 17, 2024

Dec 17, 2024

Foghorn Therapeutics' (FHTX) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Dec 17, 2024

Dec 17, 2024

Foghorn Therapeutics Advances Precision Oncology Pipeline - Yahoo Finance

Dec 17, 2024

Dec 16, 2024

Foghorn Therapeutics' SWOT analysis: chromatin pioneer's stock faces pivotal moment - Investing.com Canada

Dec 16, 2024

Dec 16, 2024

Foghorn Therapeutics Stock Slides On Cancer Drug Development Halt, But Retail Remains Upbeat - MSN

Dec 16, 2024

Dec 16, 2024

Jefferies Financial Group Has Lowered Expectations for Foghorn Therapeutics (NASDAQ:FHTX) Stock Price - MarketBeat

Dec 16, 2024

Dec 16, 2024

Why Foghorn Therapeutics (FHTX) Stock Is Trading Lower - Benzinga

Dec 16, 2024

Dec 16, 2024

Foghorn Therapeutics Inc. Provides Update on FHD-286 Clinical Development Program and Strategic Priorities - Marketscreener.com

Dec 16, 2024

Dec 16, 2024

Foghorn shifts focus from AML drug FHD-286 - Investing.com

Dec 16, 2024

Dec 16, 2024

Foghorn Therapeutics Ends Solo Development of FHD-286 - MarketWatch

Dec 16, 2024

Dec 16, 2024

Foghorn Therapeutics Provides Update on FHD-286 Clinical Development Program and Strategic Priorities - The Manila Times

Dec 16, 2024

Dec 16, 2024

Foghorn Therapeutics Halts Key AML Drug Development After Phase 1 Results Fall Short - StockTitan

Dec 16, 2024

Dec 13, 2024

After Plunging -30.17% in 4 Weeks, Here's Why the Trend Might Reverse for Foghorn Therapeutics (FHTX) - MSN

Dec 13, 2024

Dec 12, 2024

This Foghorn Therapeutics Insider Reduced Their Stake By 13% - Simply Wall St

Dec 12, 2024

Nov 30, 2024

Foghorn Therapeutics (FHTX) Upgraded to Buy: Here's Why - MSN

Nov 30, 2024

Nov 29, 2024

How the (FHTX) price action is used to our Advantage - Stock Traders Daily

Nov 29, 2024

Nov 26, 2024

Wall Street Analysts See a 104.08% Upside in Foghorn Therapeutics (FHTX): Can the Stock Really Move This High? - MSN

Nov 26, 2024

Nov 19, 2024

(FHTX) Technical Pivots with Risk Controls - Stock Traders Daily

Nov 19, 2024

Nov 18, 2024

Foghorn Therapeutics patents new CBP degradation inducers - BioWorld Online

Nov 18, 2024

Nov 13, 2024

Foghorn Therapeutics (FHTX) Collaborates with Eli Lilly and Surpasses Q3 Expectations - Nasdaq

Nov 13, 2024

Nov 12, 2024

Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences - The Manila Times

Nov 12, 2024

Nov 08, 2024

(FHTX) Trading Report - Stock Traders Daily

Nov 08, 2024

Nov 08, 2024

What is HC Wainwright’s Estimate for FHTX FY2024 Earnings? - Defense World

Nov 08, 2024

Nov 08, 2024

Wedbush Lifts Earnings Estimates for Foghorn Therapeutics - Defense World

Nov 08, 2024

Nov 07, 2024

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Just Released Its Third-Quarter Earnings: Here's What Analysts Think - Simply Wall St

Nov 07, 2024

Nov 07, 2024

Analysts Have Made A Financial Statement On Foghorn Therapeutics Inc.'s (NASDAQ:FHTX) Third-Quarter Report - Yahoo Finance

Nov 07, 2024

Nov 07, 2024

Research Analysts Issue Forecasts for FHTX FY2024 Earnings - MarketBeat

Nov 07, 2024

Nov 07, 2024

HC Wainwright Has Bullish Estimate for FHTX FY2024 Earnings - MarketBeat

Nov 07, 2024

Nov 06, 2024

We Think Foghorn Therapeutics (NASDAQ:FHTX) Needs To Drive Business Growth Carefully - Yahoo Finance

Nov 06, 2024

Nov 06, 2024

Foghorn Therapeutics Inc (FHTX) Q3 2024 Earnings: Revenue Surpas - GuruFocus.com

Nov 06, 2024

Nov 05, 2024

Foghorn Therapeutics Inc. (FHTX) Reports Q3 Loss, Misses Revenue Estimates - MSN

Nov 05, 2024

Nov 04, 2024

Foghorn Therapeutics Reports Third Quarter Highlights - TipRanks

Nov 04, 2024

Nov 04, 2024

Foghorn Therapeutics Provides Third Quarter 2024 Financial and Corporate Update - GlobeNewswire

Nov 04, 2024

Oct 27, 2024

(FHTX) Investment Report - Stock Traders Daily

Oct 27, 2024

Oct 26, 2024

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Shares Sold by Raymond James & Associates - Defense World

Oct 26, 2024

Oct 22, 2024

Foghorn Therapeutics Inc.'s (NASDAQ:FHTX) 28% Share Price Plunge Could Signal Some Risk - Simply Wall St

Oct 22, 2024